Genetic architecture of cancer and other complex diseases: lessons learned and future directions.
about
Genomics era and complex disorders: Implications of GWAS with special reference to coronary artery disease, type 2 diabetes mellitus, and cancersBiomarkers of genome instability and cancer epigenetics.The dichotomy of p53 regulation by noncoding RNAs.Significant overlap between human genome-wide association-study nominated breast cancer risk alleles and rat mammary cancer susceptibility loci.From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseasesHow can polygenic inheritance be used in population screening for common diseases?A survey of tools for variant analysis of next-generation genome sequencing data.CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.Genetic simulation tools for post-genome wide association studies of complex diseasesAllelic variation, aneuploidy, and nongenetic mechanisms suppress a monogenic trait in yeast.Genetic diversity is a predictor of mortality in humansA genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer.Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.PredictSNP2: A Unified Platform for Accurately Evaluating SNP Effects by Exploiting the Different Characteristics of Variants in Distinct Genomic Regions.Genetically determined inflammatory-response related cytokine and chemokine transcript profiles between mammary carcinoma resistant and susceptible rat strainsFrontiers in cancer epidemiology: a challenge to the research community from the Epidemiology and Genomics Research Program at the National Cancer Institute.Gene variants in the angiogenesis pathway and prostate cancer.Association between APE1 Asp148Glu polymorphism and the risk of urinary cancers: a meta-analysis of 18 case-control studies.Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer.Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms?Children's Oncology Group's 2013 blueprint for research: epidemiologyGWAS meets TCGA to illuminate mechanisms of cancer predisposition.Genotype to phenotype via network analysis.Next generation sequencing and a new era of medicine.Genetic predisposition to radiation-related cancer and potential implications for risk assessment.High-throughput gene expression and mutation profiling: current methods and future perspectives.A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizesUpregulation of FAM84B during prostate cancer progression.A symbiotic liaison between the genetic and epigenetic code.Gene interference strategies as a new tool for the treatment of prostate cancer.Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer?Differential 12-O-Tetradecanoylphorbol-13-acetate-induced activation of rat mammary carcinoma susceptibility Fbxo10 variant promoters via a PKC-AP1 pathway.Classification of Cancer Primary Sites Using Machine Learning and Somatic Mutations.A framework for how environment contributes to cancer risk.Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases.MRPL53, a New Candidate Gene for Orofacial Clefting, Identified Using an eQTL Approach.Pathways of topological rank analysis (PoTRA): a novel method to detect pathways involved in hepatocellular carcinoma.Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population.Genetic variation affecting exon skipping contributes to brain structural atrophy in Alzheimer's disease.
P2860
Q26740000-FC331A16-625B-4BEE-BC4B-C66A5D307775Q30248745-34526DFF-6500-4CA3-96CC-B47294A5CBACQ33668469-BEF0E096-B4B0-4AF2-A50B-AE787F91A8A0Q33745676-06E41F47-BE27-4541-8427-3603E18D1E6AQ34274496-50DCABCC-E862-482B-ABBC-86FE2311C593Q34327946-7F90ECD9-4DA5-4050-AAB4-53EFA38EC2DBQ34557864-13D25023-4DED-4C11-B63E-BDCE554493C0Q34560743-494B2641-D1E4-4602-859B-E0FC2BA04283Q34734512-A06D04C6-6561-4B5C-9D64-17929BE62DDDQ34864297-28AB2ADC-3C48-4102-8B9C-2E077E1A7CD9Q34994405-2B7A86CA-E6AB-4982-8937-87DDBC23C3B0Q35093501-209CC7B4-1CFA-4D72-AD76-BF6077AB1F9AQ35112029-C2C60953-1628-4DCF-AA9B-AF8FF4C314E9Q36029474-D9FCFB58-C5D2-47AC-89DF-E81354A1635CQ36040770-C0E0236D-2E8B-4451-88BB-AB3ABF825BC6Q36083974-A4604289-BF33-40C9-B439-9C2FE437E65BQ36118876-3404BCC8-AA7F-43E8-949E-364DC27AF08AQ36710139-C9763145-E7B0-4C28-B566-D9EF2F33E38CQ36840576-FFEAEDB5-BAAA-441C-9647-7A20EDB88C87Q37007328-0785AAAB-E9D7-4180-9E64-73E1B1DBAF64Q37052986-EBB0952E-44EC-43BD-8C4D-BD81672362A8Q37270019-5EA6A3F5-951B-4C24-8C29-D0340316BF90Q37399103-2F76D916-3198-4C81-875E-22E1AC184CF3Q37409165-2727BEA8-5EF2-4002-B233-BECD273205A5Q37564554-27CFC9BB-DEC9-4D13-BC59-EB1D9172FBE8Q37573642-4FBEDE45-A5D6-4716-8891-754B9C705C29Q37585898-E6BA4AD1-64E6-4B9D-B511-2135CE60988AQ37745966-8CC6CB5A-FCE3-449F-8817-1F5C3DEA11F3Q38211430-0B466898-6E2A-49D0-A6C0-BA1339A3BBF2Q38518046-DDA22116-8006-445D-AB27-E5857485D70BQ38591731-06B44821-60E5-4E8C-8636-14B28A7C0B5EQ39099598-B006186C-7FB0-402D-8078-5CB8351E013EQ40353534-E3392421-B2FE-4444-B062-A0812BAFFAB3Q40379657-1DE29B63-66D3-40AD-95CF-307F3D7AF64FQ47251942-13D1FDEA-50D6-4C26-B0BB-9D7E77F99A9CQ47624438-BAD07AB3-233D-4084-BE75-E1B0ECA36889Q52318559-07BD4805-70C4-4E12-B55C-7009C6E8B729Q53384592-39848A30-0382-441C-AA72-3AF35BD6EE3DQ55360400-0F4BF97F-8D70-4CD8-A082-1EC7BC89E31C
P2860
Genetic architecture of cancer and other complex diseases: lessons learned and future directions.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genetic architecture of cancer ...... learned and future directions.
@ast
Genetic architecture of cancer ...... learned and future directions.
@en
type
label
Genetic architecture of cancer ...... learned and future directions.
@ast
Genetic architecture of cancer ...... learned and future directions.
@en
prefLabel
Genetic architecture of cancer ...... learned and future directions.
@ast
Genetic architecture of cancer ...... learned and future directions.
@en
P2860
P356
P1433
P1476
Genetic architecture of cancer ...... learned and future directions.
@en
P2093
Elizabeth M Gillanders
Lucia A Hindorff
P2860
P304
P356
10.1093/CARCIN/BGR056
P407
P50
P577
2011-03-31T00:00:00Z